You are here

Kayvon Modjarrad, M.D., Ph.D.

Director for Emerging Infectious Diseases

Dr. Kayvon Modjarrad is Director for Emerging Infectious Diseases at the Walter Reed Army Institute of Research and an Assistant Professor of Medicine at the Uniformed Services University of Health Sciences. Dr. Modjarrad leads the U.S. Army's development of a vaccine against COVID-19 and co-leads all of WRAIR’s COVID-19 response efforts. Dr. Modjarrad's team developed a vaccine that is based on a nanoparticle platform that will enter a Phase I clinical trial later this year.

Dr. Modjarrad began his training in biology at Duke University and then went on to obtain his MD, MPH and PhD through the NIH-funded Medical Scientist Training Program. In the course of this training, Dr. Modjarrad went to Lusaka, Zambia, in 2003-2004 as a Boren Fellow, where he established a research clinic, implemented a study to evaluate the impact of parasitic infections on HIV, and bolstered local infrastructure in preparation for the U.S. President’s Emergency Plan for AIDS Relief. He then went on to complete his Internship and Residency in Internal Medicine and Fellowship in Infectious Diseases at Yale, Vanderbilt, and the NIH. 

He has published more than 70 peer-reviewed manuscripts and has served as the principal editor for two textbooks, most recently one on emerging vaccine technologies. Dr. Modjarrad also serves as the Deputy Editor in Chief for the Journal of the International AIDS Society, and is a Faculty Member for Faculty1000.